Table 4 Summary of the dose assessment for the recurrence volumes
From: Assessment and topographic characterization of locoregional recurrences in head and neck tumours
Type | Group | Vol ± SD/cm 3 | Presc D/Gy | D mean ± SD [min-max] | D 98% ± SD [min-max] |
|---|---|---|---|---|---|
Local | CTV-T (def.) | 14.0 ± 14.4 | 70.2 | 69.6 ± 2.4 [66.6 – 74.2] | 65.5 ± 2.5 [63.1 – 70.8] |
CTV-T (post-op) | 9.3 ± 12.8 | 59.4-64.8 | 60.3 ± 4.6 [57.1 – 65.6] | 58.4 ± 5.8 [54.8 – 65.1] | |
CTV-N (3 cases) | 1.4 ± 1.1 | 70.2 | 69.1 ± 0.8 [68.4 – 69.9] | 66.6 ± 1.8 [64.7 – 68.3] | |
Regional | CTV-N1 | 14.5 ± 18.0 | 54-59.4 | 57.9 ± 6.4 [52.2 – 68.3] | 48.6 ± 16.8 [21.5 – 66.9] |
CTV-N2 | 15.6 ± 16.3 | 50.4 | 50.4 ± 1.3 [49.4 – 51.3] | 39.3 ± 10.2 [32.1 – 46.5] | |
Outfield | 19.5 ± 26.8 | 31.4 ± 17.0 [8.9 – 54.6] | 21.5 ± 20.3 [0.7 – 52.1] |